BRD4 Inhibition Attenuated Phosphorylated NF-κB and Blocked the Activation of NLRP3/ASC/Caspase 1 Inflammasome Complex in Endotoxemia Colon. Here, NFKB1 is linked to serum lipopolysaccharide activity.